MME and breast cancer: To investigate the contribution of CD10 in CAFs to tumor stemness and chemoresistance, we employed a coculture model consisting of breast tumor cells and primary CAFs isolated as previously described.[25] CD10 was knocked down in CD10+GPR77+ primary CAFs isolated from breast cancer tissues of patients (Figure S2A–C, Supporting Information).